These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12945078)

  • 1. Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre.
    Bhagat MC; Dhaliwal SS; Bonnema SJ; Hegedüs L; Walsh JP
    Br J Surg; 2003 Sep; 90(9):1103-12. PubMed ID: 12945078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between endocrinologists and endocrine surgeons in management of the solitary thyroid nodule.
    Walsh JP; Ryan SA; Lisewski D; Alhamoudi MZ; Brown S; Bennedbaek FN; Hegedüs L
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):844-53. PubMed ID: 17437521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Danish endocrinologists' examination and treatment of non-toxic multinodular goiter. A questionnaire study].
    Bonnema SJ; Bennedbaek FN; Hegedüs L
    Ugeskr Laeger; 2001 Feb; 163(9):1265-9. PubMed ID: 11258250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the nontoxic multinodular goitre: a European questionnaire study.
    Bonnema SJ; Bennedbaek FN; Wiersinga WM; Hegedüs L
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):5-12. PubMed ID: 10931075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of solitary thyroid nodule--study and evaluation in Portugal].
    Vilar H; Carrilho F; Borges F; Limbert E; Rodrigues F; Oliveira MJ; Castro JJ;
    Acta Med Port; 2005; 18(6):403-8. PubMed ID: 16684479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
    Taniyama M; Ishikawa N; Momotani N; Ito K; Ban Y
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):121-4. PubMed ID: 11167935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and primary care practitioners differ?
    Dietlein M; Wegscheider K; Vaupel R; Schmidt M; Schicha H
    Nuklearmedizin; 2007; 46(3):65-75. PubMed ID: 17549317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the nontoxic multinodular goiter: a North American survey.
    Bonnema SJ; Bennedbaek FN; Ladenson PW; Hegedüs L
    J Clin Endocrinol Metab; 2002 Jan; 87(1):112-7. PubMed ID: 11788632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Graves' disease in Australia.
    Walsh JP
    Aust N Z J Med; 2000 Oct; 30(5):559-66. PubMed ID: 11108065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
    Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
    Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey.
    Diehl LA; Garcia V; Bonnema SJ; Hegedüs L; Albino CC; Graf H;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):117-23. PubMed ID: 15483102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.
    Kaniuka S; Lass P; Sworczak K
    Nucl Med Rev Cent East Eur; 2009; 12(1):23-9. PubMed ID: 19554518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
    Fast S; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)].
    Cattaneo F; Bürgi U; Mueller B
    Ther Umsch; 1999 Jul; 56(7):356-63. PubMed ID: 10434771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinodular goiter management in Western Saudi Arabia.
    Qari FA
    Saudi Med J; 2005 Mar; 26(3):438-41. PubMed ID: 15806215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of patients with euthyroid goiter].
    Hermus AR; Huysmans DA
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1623-7. PubMed ID: 10972051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.